Managing Psychiatric Evaluations and Medication Documentation in Maryland OMHCs

Psychiatric evaluations and medication management visits are among the highest-reimbursement services an OMHC provides — and among the most frequently under-documented. The psychiatrist or psychiatric nurse practitioner sees 15–20 clients a day, spends 15–20 minutes per medication management visit, and is expected to produce documentation that satisfies clinical standards, COMAR requirements, Medicaid billing rules, and malpractice liability protection. Something usually gives, and it is usually the documentation.

The consequences are predictable: claims denied for insufficient documentation, authorization requests rejected because the clinical rationale was not clearly stated, and survey findings that cite incomplete psychiatric evaluations. Meanwhile, the prescriber is already behind schedule and the next client is waiting.

This guide addresses the documentation requirements for psychiatric services in Maryland OMHCs, the most common gaps, and practical approaches to producing compliant documentation without adding 30 minutes to an already packed day.

The Initial Psychiatric Evaluation

The initial psychiatric evaluation is the foundational document for all subsequent medication management. It establishes the diagnosis, the clinical rationale for pharmacological treatment, and the baseline against which medication response will be measured. COMAR and Medicaid require that this evaluation be comprehensive, and "comprehensive" has specific meaning in this context.

Required Elements

Chief complaint and presenting symptoms. In the client's own words where possible, supplemented by the clinician's observations. Include onset, duration, severity, and functional impact.

Psychiatric history. Prior diagnoses, previous psychiatric hospitalizations, prior medication trials (with response and reason for discontinuation for each), history of suicidal ideation or attempts, and history of aggressive or violent behavior. This history is critical for medication selection and for documenting that the prescriber considered and ruled out alternatives.

Substance use history. Current and past substance use, including alcohol, cannabis, opioids, stimulants, and any others. Substance use directly affects medication selection (SSRIs interact differently in the context of active alcohol use), and undocumented substance use is a liability risk.

Medical history and current medications. Medical comorbidities, current non-psychiatric medications, known allergies, and any relevant lab results. Drug-drug interactions are a patient safety concern and a documentation requirement.

Family psychiatric history. First-degree relatives with psychiatric diagnoses, substance use disorders, or suicide. Family history informs both diagnosis and medication selection (a family history of bipolar disorder in a client presenting with depression changes the prescribing calculus significantly).

Mental status examination. A structured assessment of the client's current mental state: appearance, behavior, speech, mood (client-reported), affect (clinician-observed), thought process, thought content (including suicidal and homicidal ideation), perception (hallucinations, illusions), cognition (orientation, memory, concentration), insight, and judgment. The MSE is not optional — it is the clinical snapshot that supports the diagnosis and treatment decisions.

Diagnosis. DSM-5-TR diagnoses with sufficient clinical support. If the diagnosis is provisional or requires further evaluation, document that explicitly. Each diagnosis should be supportable by the symptoms and history documented earlier in the evaluation.

Treatment plan and medication rationale. What medication is being prescribed, at what dose, and why this medication was selected over alternatives. Document the clinical rationale: "Starting sertraline 50mg daily for moderate major depressive disorder. Selected over other SSRIs due to favorable side effect profile and absence of contraindications. Discussed with client: expected onset of therapeutic effect (2–4 weeks), common side effects (nausea, headache, initial anxiety), and importance of follow-up in 2 weeks to assess response and tolerability."

Informed consent. Documentation that the client was informed of the medication's purpose, expected benefits, common and serious side effects, alternatives (including no medication), and that they consented to treatment. A signed medication consent form should be in the chart.

Common Gaps in Initial Evaluations

Incomplete medication history. "Client has tried antidepressants in the past" is not a medication history. A proper history lists each medication tried, the dose, the duration of the trial, the clinical response, and the reason for discontinuation. This information drives current prescribing decisions and documents that the prescriber exercised due diligence.

Missing MSE. Some prescribers document a narrative impression without a structured mental status examination. This is insufficient. The MSE provides the objective clinical data that supports the diagnosis. Without it, the evaluation is a subjective narrative without clinical grounding.

Diagnosis without supporting documentation. A diagnosis of bipolar II disorder requires documentation of at least one hypomanic episode and one major depressive episode meeting DSM-5-TR criteria. If the evaluation lists the diagnosis but the symptom documentation does not include hypomanic symptoms, the diagnosis is unsupported. Reviewers check for this.

No medication rationale. "Starting Lexapro 10mg" without any explanation of why this medication was chosen. The rationale does not need to be a literature review — a sentence or two connecting the medication selection to the clinical presentation is sufficient. But its absence suggests that the prescribing decision was not deliberated, which is a quality and liability concern.

Medication Management Visit Documentation

Follow-up medication management visits are shorter (15–20 minutes) and the documentation should be correspondingly focused. But "shorter" does not mean "less structured." Each medication management note should include:

Interval history. What has changed since the last visit? Symptom status (improved, worsened, stable), medication adherence (is the client taking the medication as prescribed?), side effects (any new or worsening side effects?), and any relevant life events or stressors.

Current medications with doses. Every medication the client is currently taking, including non-psychiatric medications. This should be reconciled at every visit — clients start and stop medications between visits, and an outdated medication list is a safety hazard.

Targeted mental status examination. A full MSE is not required at every med management visit, but a targeted assessment of the domains most relevant to the client's diagnosis and treatment should be documented. For a client being treated for depression: mood, affect, suicidal ideation, sleep, appetite, energy, and concentration. For a client on an antipsychotic: thought process, thought content, perception, and any extrapyramidal symptoms.

Clinical assessment. The prescriber's assessment of the client's current status in the context of their treatment. Is the medication working? Are the symptoms responding? Are side effects manageable? Is the dose appropriate?

Plan. What changes are being made (dose adjustment, new medication, discontinuation, lab order) and the clinical rationale for each change. If no changes are made, document why the current regimen is being continued. Next follow-up date.

The Efficiency Challenge

Prescribers in high-volume OMHC settings see 15–20 clients per medication management day. At 15 minutes per visit with 5 minutes for documentation, that is a 6–7 hour clinical day with no margin. The documentation has to be fast without being incomplete.

Practical approaches that work:

Structured templates with smart defaults. A medication management note template that pre-populates the current medication list from the last visit, carries forward the diagnosis, and provides structured fields for interval history, MSE, assessment, and plan. The prescriber fills in what changed rather than rebuilding the note from scratch.

Medication list reconciliation as a clinical activity, not a documentation task. Reconcile the medication list with the client during the visit ("Are you still taking everything on this list? Anything new from your primary care doctor?"). The reconciliation is both clinically necessary and documentation-efficient — you are updating the chart while conducting the clinical encounter.

Dictation or voice-to-text for narrative sections. The interval history and assessment sections benefit from narrative documentation, and many prescribers can dictate a clinically rich paragraph faster than they can type checkbox responses.

Co-documentation with the client present. Some prescribers complete the note during the visit, reviewing key elements with the client ("I'm going to note that your mood has improved but sleep is still a concern — does that match your experience?"). This produces better documentation, ensures accuracy, and satisfies the client-involvement requirement.

Diagnosis Updates

Diagnoses change. A client initially diagnosed with major depressive disorder may, over the course of treatment, present with hypomanic symptoms that warrant a diagnostic revision to bipolar II. A client diagnosed with generalized anxiety disorder may develop symptoms consistent with PTSD after a traumatic event.

When diagnoses change, the documentation requirements are specific:

Document the clinical basis for the change. What new symptoms, observations, or information led to the diagnostic revision? When did the new presentation emerge?

Update the treatment plan. A diagnostic change almost always implies a treatment plan change. If the diagnosis shifts from MDD to bipolar II, the medication strategy may change fundamentally (discontinuing an SSRI monotherapy, initiating a mood stabilizer). Document the treatment plan revision with clinical rationale.

Communicate to the treatment team. In an OMHC where the client also sees a therapist, the therapist needs to know about diagnostic changes because it affects their treatment approach. Document the communication — a diagnosis update note that is visible to the full treatment team, or a coordination of care note documenting the discussion.

Update authorization if applicable. Some Medicaid authorizations are diagnosis-specific. A diagnostic change may require a new or modified authorization. Flag this for your billing team.